A groundbreaking study from the Medical University of South Carolina is challenging the long-held assumption that fish oil supplements are universally beneficial, particularly for individuals who have suffered repeated mild traumatic brain injuries. While omega-3 fatty acids are widely marketed as neuroprotective agents, new research published in the journal Cell Reports suggests that these supplements may inadvertently interfere with the brain’s complex healing processes.
Led by neuroscientist Dr. Onder Albayram, the team focused on how these fats affect the repair of blood vessels in the brain after injury. The findings indicate that the specific omega-3 component known as eicosapentaenoic acid (EPA) might create a metabolic vulnerability that hinders recovery rather than aiding it.
As reported by Science Daily, the research highlights a critical distinction between different types of omega-3s. While docosahexaenoic acid (DHA) is well-regarded for its role in supporting neuronal membranes, EPA behaves differently, with effects that can vary based on the biological environment.
The study found that higher levels of EPA in the brain were associated with weaker repair mechanisms after injury. Specifically, EPA appeared to reprogram gene expression, suppressing the signaling pathways required for blood vessel stability and endothelial integrity.
Read more: Trump announces marijuana as less dangerous drug (with video)
This disruption led to a buildup of perivascular tau, a protein accumulation often associated with cognitive decline and chronic traumatic encephalopathy (CTE), suggesting that the body’s method of handling these fatty acids is highly sensitive to the presence of brain trauma.
To validate these findings, the research team utilized a comprehensive approach that connected diet, brain function, and healing. Using mouse models, they observed that long-term fish oil intake resulted in poorer neurological performance and spatial learning following head impacts.
These findings were further corroborated by experiments on human brain microvascular endothelial cells, which form the vital barrier between the blood and the brain; in these cells, EPA consistently reduced the capacity for repair.
The team’s analysis of postmortem brain tissue from individuals diagnosed with CTE confirmed evidence of disrupted fatty acid balance, providing a crucial translational link that suggests these laboratory findings have significant relevance to human neurodegeneration and clinical outcomes.
Dr. Albayram emphasized that this research should not be viewed as a blanket condemnation of fish oil, but rather as an argument for the necessity of precision nutrition. Because biological responses are context-dependent, the long-term impacts of supplementation may differ drastically depending on an individual’s health status, dietary habits, and history of injury.
